These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37872650)

  • 21. Bazedoxifene, a new orphan drug for the treatment of bleeding in hereditary haemorrhagic telangiectasia.
    Zarrabeitia R; Ojeda-Fernandez L; Recio L; Bernabéu C; Parra JA; Albiñana V; Botella LM
    Thromb Haemost; 2016 Jun; 115(6):1167-77. PubMed ID: 26818701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hereditary haemorrhagic telangiectasia.
    Magalhães-Costa P; Chagas C
    BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25576516
    [No Abstract]   [Full Text] [Related]  

  • 23. Hereditary HaemorrhagicTelangiectasia--A Rare Cause of Severe Anaemia.
    Deshpande P; Bhat S; Karmarkar A
    J Assoc Physicians India; 2014 Dec; 62(12):48-51. PubMed ID: 26259423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of TIMOLOL nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia. A double-blind, randomized, placebo-controlled trial.
    Dupuis-Girod S; Pitiot V; Bergerot C; Fargeton AE; Beaudoin M; Decullier E; Bréant V; Colombet B; Philouze P; Faure F; Letievant JC
    Sci Rep; 2019 Aug; 9(1):11986. PubMed ID: 31427745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D levels are associated with epistaxis severity and bleeding duration in hereditary hemorrhagic telangiectasia.
    Weber LM; McDonald J; Whitehead K
    Biomark Med; 2018 Apr; 12(4):365-371. PubMed ID: 29537299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of propranolol for epistaxis in hereditary haemorrhagic telangiectasia: retrospective, then prospective study, in a total of 21 patients.
    Contis A; Gensous N; Viallard JF; Goizet C; Léauté-Labrèze C; Duffau P
    Clin Otolaryngol; 2017 Aug; 42(4):911-917. PubMed ID: 28032956
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of Hereditary Hemorrhagic Telangiectasia-Related Epistaxis.
    Sautter NB; Smith TL
    Otolaryngol Clin North Am; 2016 Jun; 49(3):639-54. PubMed ID: 27267016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chronic anaemia in a patient with hereditary haemorrhagic telangiectasia and juvenile gastric polyposis].
    Blaas SH; Röckelein G; Wilke J; Weinerth JD; Dobroschke J; Schölmerich J; Müller-Ladner U
    Dtsch Med Wochenschr; 2006 Aug; 131(33):1803-6. PubMed ID: 16902903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia.
    Fiorella ML; Ross D; Henderson KJ; White RI
    Laryngoscope; 2005 Feb; 115(2):301-5. PubMed ID: 15689755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Convexity subarachnoid haemorrhage secondary to hereditary haemorrhagic telangiectasia.
    Sancho Saldaña A; Lambea Gil Á; Sánchez Marín B; Gazulla J
    Neurologia (Engl Ed); 2020; 35(6):432-433. PubMed ID: 29898856
    [No Abstract]   [Full Text] [Related]  

  • 31. A novel treatment for patients with hereditary haemorrhagic telangiectasia.
    Farnan TB; Gallagher G; Scally CM
    J Laryngol Otol; 2002 Oct; 116(10):849-50. PubMed ID: 12437844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ophthalmologic diagnosis of hereditary hemorrhagic telangiectasia or Rendu-Osler-Weber disease].
    Pizzamiglio-Martín C; Gil-Cazorla R; Guzmán-Glázquez J
    Arch Soc Esp Oftalmol; 2008 Jun; 83(6):381-4. PubMed ID: 18521772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hereditary haemorrhagic telangiectasia.
    Sharathkumar AA; Shapiro A
    Haemophilia; 2008 Nov; 14(6):1269-80. PubMed ID: 19141168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrointestinal manifestations of hereditary haemorrhagic teleangiectasia.
    Kristoffersson A; Domellöf L; Kullenberg K
    Ann Chir Gynaecol; 1987; 76(2):96-8. PubMed ID: 3497606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The treatment of recurrent epistaxis due to hereditary haemorrhagic telangiectasia with intranasal bevacizumab.
    Alderman C; Corlett J; Cullis J
    Br J Haematol; 2013 Aug; 162(4):547-8. PubMed ID: 23672440
    [No Abstract]   [Full Text] [Related]  

  • 36. Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia-Related Epistaxis and Gastrointestinal Bleeding.
    Iyer VN; Apala DR; Pannu BS; Kotecha A; Brinjikji W; Leise MD; Kamath PS; Misra S; Begna KH; Cartin-Ceba R; DuBrock HM; Krowka MJ; O'Brien EK; Pruthi RK; Schroeder DR; Swanson KL
    Mayo Clin Proc; 2018 Feb; 93(2):155-166. PubMed ID: 29395350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective analysis of submucosal radiofrequency procedure for the treatment of nasal bleeding in 44 patients with hereditary haemorrhagic telangiectasia.
    Hochet B; Achard S; Maillard H; Mortuaire G
    Clin Otolaryngol; 2019 Nov; 44(6):1138-1141. PubMed ID: 31433905
    [No Abstract]   [Full Text] [Related]  

  • 38. Stopping bleeding in hereditary telangiectasia.
    Phillips MD
    N Engl J Med; 1994 Jun; 330(25):1822-3. PubMed ID: 8190162
    [No Abstract]   [Full Text] [Related]  

  • 39. Worsening of nose bleeding heralds high cardiac output state in hereditary hemorrhagic telangiectasia.
    Khalid SK; Pershbacher J; Makan M; Barzilai B; Goodenberger D
    Am J Med; 2009 Aug; 122(8):779.e1-9. PubMed ID: 19635281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intractable bleeding from the renal pelvis in a patient with hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease).
    Qvigstad LF; Grøtta OJ; Hammarström C; Baco E
    Scand J Urol; 2020 Oct; 54(5):449-451. PubMed ID: 32720548
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.